Answers are grounded in this paper and cite their sources.
Clinical trial shows long-term improvements in migraine control for individuals after failed preventive treatments, indicating potential benefits of eptinezumab.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ailani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: